Acadia Healthcare Company Inc. (ACHC)
NASDAQ: ACHC · Services-Specialty Outpatient Facilities, NEC · Franklin, TN
Our rating: Cautious
Cautious reaffirmed at $32.25, high conviction, November 4, 2026.
Breaks if: The Cautious view is wrong if Acadia reports trailing-twelve-month free cash flow above zero across any two consecutive quarterly filings within the next 12 months — a genuine, sustained reversal from the current -$440M run rate. A stock that sustains above $46 (roughly 43% above today's level) over a 12-month window would signal the market has priced in a recovery the current figures do not support, and would warrant a fresh read of the thesis.
Key figures
| Market value | $3.2B |
|---|---|
| Revenue, last 12 months | $3.4B |
| Net income, last 12 months | −$1.1B |
| Free cash flow, last 12 months | −$24M |
| Price to earnings | n/a |
| Free cash flow yield | −0.7% |
| Dividend yield | 0.0% |
| Operating margin | n/a |
| Return on equity | −43.9% |
| Beta to the S&P 500 | 0.69 |
| Volatility, annualized | 59.8% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $895M | 5.1% | $0.38 | $47M |
| June 30, 2026 | $866M | −0.4% | $0.12 | $124M |
| March 31, 2026 | $829M | 7.6% | $0.05 | −$15M |
| December 31, 2025 | $821M | 6.1% | $-12.98 | −$179M |
| September 30, 2025 | $852M | 4.4% | $0.40 | −$63M |
| June 30, 2025 | $869M | 9.2% | $0.33 | −$34M |
| March 31, 2025 | $771M | 0.3% | $0.09 | −$163M |
| December 31, 2024 | $774M | 4.2% | $0.36 | −$87M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.86B: Claude 62%, Gemini 88%, Mistral 82%
- Diluted earnings per share are above zero: Claude 82%, Gemini 95%, Mistral 85%
- Free cash flow for the quarter is above zero: Claude 65%, Gemini 35%, Mistral 60%
14 ledger entries and 71 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.